SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ZIM Laboratories informs about newspaper advertisements

15 Jun 2023 Evaluate

Pursuant to Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in compliance with various circulars issued by the Ministry of Corporate Affairs, ZIM Laboratories has submitted copies of newspaper advertisements published, intimating that the 39th Annual General Meeting of the Company is scheduled to be held on Monday, 10th July, 2023 through Video Conferencing (VC) / Other Audio Visual Means (OAVM) in the Newspapers, The Financial Express (English) all India Edition, Indian Express (English), Nagpur Edition and Loksatta (Marathi).

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

80.00 0.28 (0.35%)
20-Apr-2026 14:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.90
Dr. Reddys Lab 1235.10
Cipla 1232.95
Zydus Lifesciences 936.50
Lupin 2327.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×